Barclays’s SEQUENOM INC NEW SQNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-14,349
| Closed | -$13K | – | 7021 |
|
|
2016
Q2 | $13K | Buy |
14,349
+13,660
| +1,983% | +$16.3K | ﹤0.01% | 5463 |
|
|
2016
Q1 | $1K | Sell |
689
-678
| -50% | -$1.01K | ﹤0.01% | 6082 |
|
|
2015
Q4 | $1K | Sell |
1,367
-62,236
| -98% | -$107K | ﹤0.01% | 5911 |
|
|
2015
Q3 | $64K | Buy |
63,603
+55,159
| +653% | +$135K | ﹤0.01% | 4886 |
|
|
2015
Q2 | $25K | Sell |
8,444
-8,483
| -50% | -$31.9K | ﹤0.01% | 5557 |
|
|
2015
Q1 | $50K | Sell |
16,927
-2,003
| -11% | -$7.36K | ﹤0.01% | 5281 |
|
|
2014
Q4 | $57K | Sell |
18,930
-157,461
| -89% | -$510K | ﹤0.01% | 5622 |
|
|
2014
Q3 | $352K | Buy |
176,391
+147,896
| +519% | +$541K | ﹤0.01% | 4265 |
|
|
2014
Q2 | $86K | Sell |
28,495
-10,290
| -27% | -$30.1K | ﹤0.01% | 5539 |
|
|
2014
Q1 | $76K | Sell |
38,785
-106,167
| -73% | -$253K | ﹤0.01% | 5674 |
|
|
2013
Q4 | $290K | Buy |
144,952
+32,846
| +29% | +$77.9K | ﹤0.01% | 4633 |
|
|
2013
Q3 | $224K | Buy |
112,106
+59,300
| +112% | +$199K | ﹤0.01% | 4934 |
|
|
2013
Q2 | $222K | Buy |
+52,806
| New | +$211K | ﹤0.01% | 5070 |
|
Barclays's SQNM Position: Q3 2016 in Review
Barclays sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 14,349 shares — an estimated $13K sold.
Barclays first reported a position in SQNM in Q2 2013 and held it in 13 quarters. The position peaked at $352K in Q3 2014. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.
- Barclays reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
- Barclays sold 14,349 SEQUENOM INC NEW shares in Q3 2016, an estimated $13K.
- Barclays first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 13 quarters.
- Barclays's SEQUENOM INC NEW position peaked at $352K in Q3 2014.
- 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.
Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.